Natural Alternatives International (NAII) Competitors $3.58 +0.14 (+3.95%) As of 02:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAII vs. TCRX, VIGL, ZURA, CLYM, IVVD, SLS, ACOG, CABA, RANI, and VTGNShould you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include TScan Therapeutics (TCRX), Vigil Neuroscience (VIGL), Zura Bio (ZURA), Climb Bio (CLYM), Invivyd (IVVD), SELLAS Life Sciences Group (SLS), Alpha Cognition (ACOG), Cabaletta Bio (CABA), Rani Therapeutics (RANI), and Vistagen Therapeutics (VTGN). These companies are all part of the "pharmaceutical products" industry. Natural Alternatives International vs. TScan Therapeutics Vigil Neuroscience Zura Bio Climb Bio Invivyd SELLAS Life Sciences Group Alpha Cognition Cabaletta Bio Rani Therapeutics Vistagen Therapeutics Natural Alternatives International (NASDAQ:NAII) and TScan Therapeutics (NASDAQ:TCRX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability, community ranking and analyst recommendations. Which has better valuation & earnings, NAII or TCRX? Natural Alternatives International has higher revenue and earnings than TScan Therapeutics. Natural Alternatives International is trading at a lower price-to-earnings ratio than TScan Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatural Alternatives International$121.85M0.18-$7.22M-$1.29-2.77TScan Therapeutics$2.82M25.62-$89.22M-$1.15-1.11 Does the media prefer NAII or TCRX? In the previous week, TScan Therapeutics had 1 more articles in the media than Natural Alternatives International. MarketBeat recorded 5 mentions for TScan Therapeutics and 4 mentions for Natural Alternatives International. TScan Therapeutics' average media sentiment score of 0.58 beat Natural Alternatives International's score of 0.40 indicating that TScan Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natural Alternatives International 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral TScan Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in NAII or TCRX? 32.4% of Natural Alternatives International shares are held by institutional investors. Comparatively, 82.8% of TScan Therapeutics shares are held by institutional investors. 20.9% of Natural Alternatives International shares are held by company insiders. Comparatively, 2.8% of TScan Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community favor NAII or TCRX? Natural Alternatives International received 231 more outperform votes than TScan Therapeutics when rated by MarketBeat users. However, 83.33% of users gave TScan Therapeutics an outperform vote while only 76.55% of users gave Natural Alternatives International an outperform vote. CompanyUnderperformOutperformNatural Alternatives InternationalOutperform Votes27176.55% Underperform Votes8323.45% TScan TherapeuticsOutperform Votes4083.33% Underperform Votes816.67% Is NAII or TCRX more profitable? Natural Alternatives International has a net margin of -6.26% compared to TScan Therapeutics' net margin of -1,188.88%. Natural Alternatives International's return on equity of -9.36% beat TScan Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Natural Alternatives International-6.26% -9.36% -4.82% TScan Therapeutics -1,188.88%-58.72%-36.02% Do analysts prefer NAII or TCRX? TScan Therapeutics has a consensus target price of $9.33, suggesting a potential upside of 632.03%. Given TScan Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe TScan Therapeutics is more favorable than Natural Alternatives International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natural Alternatives International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00TScan Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, NAII or TCRX? Natural Alternatives International has a beta of 0.6, indicating that its stock price is 40% less volatile than the S&P 500. Comparatively, TScan Therapeutics has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500. SummaryTScan Therapeutics beats Natural Alternatives International on 11 of the 18 factors compared between the two stocks. Remove Ads Get Natural Alternatives International News Delivered to You Automatically Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAII vs. The Competition Export to ExcelMetricNatural Alternatives InternationalMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.17M$1.14B$5.57B$7.84BDividend YieldN/AN/A5.37%4.05%P/E Ratio-2.779.3623.5818.67Price / Sales0.185.43370.3188.62Price / CashN/A10.4038.1734.64Price / Book0.281.176.654.10Net Income-$7.22M-$54.34M$3.20B$246.93M7 Day Performance-0.39%-4.68%-5.81%-3.62%1 Month Performance-12.78%-16.02%-1.02%-6.69%1 Year Performance-40.99%-41.59%7.66%-1.88% Natural Alternatives International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAIINatural Alternatives International0.7468 of 5 stars$3.58+4.0%N/A-43.5%$22.17M$121.85M-2.77290Short Interest ↑Gap UpTCRXTScan Therapeutics3.6129 of 5 stars$1.60-4.2%$9.33+483.3%-82.6%$90.55M$2.82M-1.51100Short Interest ↓Gap UpVIGLVigil Neuroscience4.0381 of 5 stars$1.90+0.5%$16.25+755.3%-47.8%$88.68MN/A-0.9240Short Interest ↓Positive NewsZURAZura Bio2.1505 of 5 stars$1.35-2.9%$15.80+1,070.4%-49.8%$88.15MN/A0.003Earnings ReportCLYMClimb Bio2.9977 of 5 stars$1.32+1.5%$10.00+657.6%N/A$87.39MN/A-0.629Earnings ReportGap DownIVVDInvivyd3.3385 of 5 stars$0.72-1.9%$7.89+989.4%-86.4%$86.60M$25.38M-0.37100Short Interest ↓SLSSELLAS Life Sciences Group0.386 of 5 stars$1.23+2.5%N/A+6.9%$86.57M$1M-1.7810ACOGAlpha Cognition1.906 of 5 stars$5.33-0.7%$20.00+275.2%N/A$85.39MN/A-2.08N/AEarnings ReportUpcoming EarningsAnalyst ForecastNews CoverageGap UpCABACabaletta Bio2.1533 of 5 stars$1.72-1.1%$22.71+1,220.6%-91.9%$85.05MN/A-0.8050Earnings ReportUpcoming EarningsAnalyst ForecastNews CoverageRANIRani Therapeutics2.7855 of 5 stars$1.47-5.2%$12.33+739.0%-59.5%$84.22MN/A-1.39110Earnings ReportNews CoverageVTGNVistagen Therapeutics2.015 of 5 stars$2.91+4.3%N/A-52.7%$83.99M$698,000.00-1.9740Positive News Remove Ads Related Companies and Tools Related Companies TScan Therapeutics Competitors Vigil Neuroscience Competitors Zura Bio Competitors Climb Bio Competitors Invivyd Competitors SELLAS Life Sciences Group Competitors Alpha Cognition Competitors Cabaletta Bio Competitors Rani Therapeutics Competitors Vistagen Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAII) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natural Alternatives International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natural Alternatives International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
